All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Curtability and transferability of atopy with allogeneic hematopoietic cell transplantation

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F20%3A10410773" target="_blank" >RIV/00216208:11130/20:10410773 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064203:_____/20:10410773

  • Result on the web

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=VexERIR.9Q" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=VexERIR.9Q</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1038/s41409-020-0876-7" target="_blank" >10.1038/s41409-020-0876-7</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Curtability and transferability of atopy with allogeneic hematopoietic cell transplantation

  • Original language description

    Atopy is excessive production of IgE in response to allergens. We evaluated in patients undergoing allogeneic hematopoietic cell transplantation (HCT) the following hypotheses: (1) Atopy is &quot;curable&quot; in atopic patients receiving HCT from a nonatopic donor (D-R+), and (2) Atopy is transferable from atopic donors to nonatopic recipients (D+R-). Atopic patients with atopic donors (D+R+) and non-atopic patients with non-atopic donors (D-R-) served as controls. We measured levels of multiallergen-specific IgE (A-IgE, atopy defined as &gt;= 0.35 kU(A)/L) in sera from 54 patients and their donors pre HCT and from the patients at &gt;= 2 years post HCT. Only 7/12 (58%) D- R+ patients became nonatopic after HCT. Only 1/11 (9%) D+R- patients became atopic. Eleven of 13 (85%) D-R- patients remained nonatopic. Unexpectedly, 11/18 (61%) D+R+ patients became nonatopic. In conclusion, contrary to our hypothesis and previous reports, the &quot;cure&quot; of atopy may occur in only some D-R+ patients and the transfer of atopy may occur rarely. The &quot;cure&quot; may not be necessarily due to the exchange of atopic for nonatopic immune system, as the &quot;cure&quot; may also occur in D+R+ patients.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Bone Marrow Transplantation

  • ISSN

    0268-3369

  • e-ISSN

  • Volume of the periodical

    55

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    8

  • Pages from-to

    1282-1289

  • UT code for WoS article

    000522380100004

  • EID of the result in the Scopus database

    2-s2.0-85082971385